Cell line name | NCCSEDi001-A-1 |
---|---|
Synonyms | NANS-2-6 |
Accession | CVCL_A4EG |
Resource Identification Initiative | To cite this cell line use: NCCSEDi001-A-1 (RRID:CVCL_A4EG) |
Comments | From: National Chengdu Center for Safety Evaluation of Drugs; Chengdu; China. Population: Chinese; Han. Characteristics: Using CRISPR/Cas9 GFP-P2A-Puro was integrated in both alleles of NANS exon 1 (PubMed=33130469). Knockout cell: Method=CRISPR/Cas9; HGNC; 19237; NANS. Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR). Cell type: Fibroblast; CL=CL_0000057. |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_A4EF (NCCSEDi001-A) |
Sex of cell | Male |
Age at sampling | 34Y |
Category | Induced pluripotent stem cell |
Publications | PubMed=33130469; DOI=10.1016/j.scr.2020.102052 |
Cross-references | |
Cell line databases/resources | hPSCreg; NCCSEDi001-A-1 |
Biological sample resources | BioSamples; SAMEA7222556 |
Encyclopedic resources | Wikidata; Q105510307 |
Entry history | |
Entry creation | 12-Jan-2021 |
Last entry update | 05-Oct-2023 |
Version number | 6 |